Medically reviewed by Dr. Lemuel P. Byrd, Jr., D.C., FMCSA Certified Medical Examiner | Last updated: January 28, 2026
Commercial drivers with liver conditions can obtain DOT medical certification when their condition is stable and does not cause symptoms that impair driving safety. Drivers with hepatitis, fatty liver disease, or compensated cirrhosis can typically qualify with proper documentation. The critical factors are absence of hepatic encephalopathy, no severe fatigue or cognitive impairment, stable liver function tests, and medications that don’t impair driving ability. Advanced liver failure with significant complications may be disqualifying.
At Charlotte DOT Exam Center, our FMCSA-certified examiners have extensive experience evaluating this condition.
Call 704-544-3494 | $70 flat rate | Walk-ins welcome
Liver disease affects millions of Americans, with conditions ranging from common fatty liver disease to viral hepatitis and cirrhosis. Many commercial drivers successfully manage liver conditions while maintaining their CDL careers. Understanding FMCSA requirements and proper documentation helps drivers with liver disease navigate the certification process.
The Federal Motor Carrier Safety Administration evaluates liver conditions based on functional impact rather than diagnosis alone. The primary safety concerns are hepatic encephalopathy (confusion due to liver dysfunction), severe fatigue, bleeding risks, and medication side effects. Drivers with stable, well-compensated liver disease who avoid these complications can achieve certification.
Charlotte DOT Exam Center’s FMCSA-certified medical examiners understand the complexities of liver disease evaluation for commercial drivers. We work with drivers to ensure appropriate documentation demonstrates fitness for safe commercial vehicle operation.
Liver conditions encompass a wide range of diseases affecting hepatic function. Non-alcoholic fatty liver disease (NAFLD) and its progressive form (NASH) have become increasingly common, affecting approximately 25% of Americans. Viral hepatitis (A, B, C) causes liver inflammation that can be acute or chronic. Cirrhosis represents advanced scarring from various causes including alcohol, viral hepatitis, and NAFLD. Compensated cirrhosis means the liver still functions adequately despite scarring, while decompensated cirrhosis involves serious complications like ascites, variceal bleeding, or hepatic encephalopathy.
According to the American Liver Foundation, approximately 4.5 million Americans have diagnosed liver disease, though the true prevalence is likely higher due to undiagnosed NAFLD. Hepatitis C affects approximately 2.4 million Americans, while Hepatitis B affects about 862,000. Given the association between metabolic syndrome (obesity, diabetes) and liver disease, commercial drivers may have elevated rates of fatty liver disease.
The FMCSA physical qualification standards are found in 49 CFR 391.41 – Physical Qualifications. According to the American Liver Foundation – Liver Disease Progression, liver conditions affects many Americans, including commercial drivers.
The FMCSA evaluates liver conditions based on functional capacity, your ability to safely operate a commercial motor vehicle. Key factors the medical examiner considers include:
For additional information, see the NIH NIDDK – Liver Disease Information and FMCSA Driver Medical Requirements.
Commercial drivers with liver conditions often have similar questions. Here are the most common questions we answer at Charlotte DOT Exam Center:
Yes, many drivers with liver disease pass DOT physicals and maintain their commercial driving careers. The medical examiner evaluates whether your liver condition is stable, adequately managed, and unlikely to cause symptoms that impair safe driving. Drivers with fatty liver disease, treated hepatitis, or compensated cirrhosis can typically qualify. The key requirements are stable liver function tests, absence of hepatic encephalopathy, manageable fatigue levels, and medications compatible with commercial driving.
Yes, commercial drivers with hepatitis can obtain DOT medical certification. Hepatitis A typically resolves completely and poses no long-term certification issues. Chronic Hepatitis B and C require evaluation of disease activity, liver function, and treatment status. Drivers with controlled viral hepatitis who have stable liver function and no cirrhosis complications typically qualify. Those who have achieved sustained virologic response (cure) from Hepatitis C treatment have excellent certification prospects.
Cirrhosis does not automatically disqualify you from CDL certification. The distinction is between compensated and decompensated cirrhosis. Compensated cirrhosis—where the liver maintains adequate function despite scarring—can be certifiable with proper documentation. Decompensated cirrhosis with complications like hepatic encephalopathy, significant ascites, or variceal bleeding is typically disqualifying due to safety risks. Your gastroenterologist or hepatologist’s assessment is crucial.
The medical examiner reviews liver function tests including AST, ALT, bilirubin, albumin, and INR/PT. Mildly elevated transaminases (AST/ALT) alone don’t disqualify drivers—many people with fatty liver have elevated enzymes but normal function. More concerning are elevated bilirubin (indicating impaired liver processing), low albumin (indicating impaired protein production), and prolonged INR (indicating impaired clotting factor production). The pattern and trend of results matter more than isolated values.
Hepatic encephalopathy—confusion or cognitive impairment due to liver dysfunction—is a significant safety concern for commercial driving. Active hepatic encephalopathy is disqualifying because it impairs judgment, reaction time, and alertness. Drivers with a history of hepatic encephalopathy who have achieved stable control with lactulose or rifaximin may be considered for certification with careful documentation, though this requires thorough evaluation and typically shorter certification periods.
Bring recent liver function tests (within 60-90 days) including comprehensive metabolic panel with AST, ALT, bilirubin, and albumin. Include your gastroenterologist or hepatologist’s clearance letter addressing diagnosis, disease stability, functional status, and fitness for commercial driving. If you have viral hepatitis, include viral load results. For cirrhosis, include imaging results and any varices screening. Provide a complete medication list including any supplements.
Most medications for liver disease management are compatible with commercial driving. This includes antivirals for hepatitis (sofosbuvir, ledipasvir, etc.), lactulose and rifaximin for encephalopathy prevention, beta blockers for portal hypertension, and diuretics for mild ascites. However, some drivers experience fatigue from beta blockers or GI effects from lactulose that may need evaluation. Provide your complete medication list for the examiner to review.
Yes, liver transplant recipients can obtain DOT medical certification after adequate recovery. Most transplant programs recommend waiting 6-12 months post-transplant before returning to commercial driving. You’ll need clearance from your transplant hepatologist documenting stable graft function, immunosuppressant medication compliance, and absence of complications. Post-transplant drivers typically receive annual certification requiring ongoing documentation of stable liver function.
Understanding which medications are compatible with commercial driving helps you prepare for your DOT physical and communicate effectively with your medical examiner.
| Medication Category | Common Examples | CDL Compatible? |
|---|---|---|
| Direct-Acting Antivirals (Hep C) | Sofosbuvir, Ledipasvir, Velpatasvir | ✅ |
| Hepatitis B Antivirals | Entecavir, Tenofovir | ✅ |
| Lactulose | Enulose, Kristalose | ✅ |
| Rifaximin | Xifaxan | ✅ |
| Beta Blockers (portal HTN) | Propranolol, Nadolol | ⚠️ |
| Diuretics | Spironolactone, Furosemide | ✅ |
| Ursodiol | Actigall, Urso | ✅ |
| Immunosuppressants (transplant) | Tacrolimus, Mycophenolate | ⚠️ |
| Opioid Pain Medications | Any opioids | ❌ |
| Sedatives/Benzodiazepines | Alprazolam, Lorazepam | ❌ |
Key: Yes = Compatible | Caution = Requires evaluation | No = Not compatible while driving
Your DOT medical certificate duration depends on your condition status, treatment effectiveness, and documentation provided:
| Severity Level | Characteristics | Typical Certificate | Documentation Required |
|---|---|---|---|
| Fatty Liver (NAFLD) | Elevated enzymes, no fibrosis, stable condition | 24 months | Recent labs, primary care clearance |
| NASH/Early Fibrosis | Inflammation present, mild fibrosis, stable | 12-24 months | GI/hepatology clearance, comprehensive labs |
| Chronic Hepatitis (controlled) | Viral suppression or SVR, stable function | 12-24 months | Hepatology clearance, viral load, liver function |
| Compensated Cirrhosis | Cirrhosis without complications, stable | 6-12 months | Hepatology clearance, imaging, varices status |
| Post-Liver Transplant | Stable graft function, compliant | 12 months | Transplant hepatology clearance, graft function labs |
| Situation | Typical Wait | Documentation Needed |
|---|---|---|
| Acute hepatitis episode | Full recovery | Resolution documentation, normalized liver function |
| Liver transplant | 6-12 months | Transplant team clearance, stable graft function |
| Variceal bleeding episode | 3-6 months | GI clearance, successful treatment, no rebleeding |
| Hepatic encephalopathy episode | Complete resolution | Cognitive normalization, hepatology clearance |
| Hepatocellular carcinoma treatment | Case-by-case | Oncology and hepatology clearance, no active disease |
Proper documentation streamlines your DOT physical and supports certification. Gather these items before your appointment:
Drivers with liver conditions may have related conditions also evaluated during the DOT physical:
For complete information, see our DOT Physical Medical Conditions hub page.
Liver disease does not automatically disqualify you from obtaining a CDL. The FMCSA evaluates whether your condition is stable and unlikely to cause sudden incapacitation or cognitive impairment while driving. Drivers with fatty liver disease, controlled hepatitis, or compensated cirrhosis can typically qualify with proper documentation. Advanced liver failure with hepatic encephalopathy or other serious complications may be disqualifying.
Yes, drivers with Hepatitis C can obtain DOT medical certification. Many drivers have achieved sustained virologic response (SVR/cure) with modern direct-acting antiviral treatments and have excellent certification prospects. Those with chronic Hepatitis C who haven’t been treated can still qualify if liver function is preserved and there are no cirrhosis complications. Bring viral load results and hepatology clearance to your DOT physical.
Certification frequency depends on disease severity and stability. Drivers with simple fatty liver may receive standard 24-month certificates. Those with NASH, chronic hepatitis, or early fibrosis typically receive 12-month certificates. Drivers with compensated cirrhosis or post-transplant status usually receive 6-12 month certificates. Your medical examiner determines the appropriate interval based on your condition.
Elevated liver enzymes (AST, ALT) alone do not disqualify you from DOT certification. Many people have mildly elevated enzymes from fatty liver disease without significant functional impairment. The medical examiner evaluates the degree of elevation, pattern of results, and overall liver function. Bring documentation explaining the cause of elevated enzymes and any treatment plan. Markedly elevated enzymes may require further evaluation before certification.
You must maintain a valid DOT medical certificate that reflects your current health status. When you complete the DOT physical with liver disease, this information is documented on your medical examination report. The examiner submits your certification status to the FMCSA National Registry. North Carolina CDL holders should ensure their medical certification remains current with the NC DMV.
Liver disease can cause DOT physical failure if it results in complications that impair safe driving ability. Hepatic encephalopathy (confusion from liver dysfunction), severe fatigue, or bleeding complications would typically prevent certification. However, stable liver disease—including compensated cirrhosis—with proper documentation and specialist clearance can be certified. The key is demonstrating that your condition doesn’t affect your ability to safely operate a commercial vehicle.
Charlotte DOT Exam Center provides expert DOT physical examinations for commercial drivers with liver conditions. Our FMCSA-certified medical examiners, Dr. Alan M. Tebby, D.C. and Dr. Lemuel Byrd, have extensive experience with this condition.
8415 Pineville-Matthews Road, Suite 102
Charlotte, NC 28226
Questions? Call us at 704-544-3494 to discuss your liver conditions and DOT certification requirements.